Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document concludes that injecting dutasteride into the skin (mesotherapy) can effectively treat common hair loss in both men and women.

Topical spironolactone works better than topical finasteride for hair loss.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

A boy with a rare birthmark called verrucous hemangioma needed careful timing for surgery due to its size and depth.

Spironolactone may help improve symptoms and tear quality in dry eye disease.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Use antiandrogens and other treatments for hair loss.

Saw palmetto extract may help with hair loss and acne but needs more research on safety and long-term effects.